<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">Emtricitabine is a nucleoside reverse transcriptase inhibitor which is used in AIDS treatment [
 <xref ref-type="bibr" rid="CR78">78</xref>, 
 <xref ref-type="bibr" rid="CR79">79</xref>]. It blocks the reverse transcription process of HIV by inhibiting reverse transcriptase and can also effectively inhibit hepatitis B virus (HBV) reverse transcription process [
 <xref ref-type="bibr" rid="CR77">77</xref>, 
 <xref ref-type="bibr" rid="CR80">80</xref>]. It has been reported that the combination of emtricitabine and denofovir alafenamide in clinical trial for the treatment of COVID-19 was applied with great therapeutic effects [
 <xref ref-type="bibr" rid="CR32">32</xref>].
</p>
